Cardiointervalography in patients with multiple sclerosis
https://doi.org/10.14412/2074-2711-2016-3-39-42
Abstract
Cardiovascular autonomic symptoms significantly impart quality of life in patients with multiple sclerosis (MR) and, in some cases, pose a threat to their life.
Objective: to study cardiovascular autonomic dysfunction by cardiointervalography in MS patients.
Patients and methods. Cardiovascular tests (CVT) were carried out in 47 patients with MS (a study group) and in 22 healthy individuals (a control group).
Results. Comparative analysis revealed a significant reduction in the values of basic CVTs (Cresp, C30:15, and CVals) in MS patients (p<0.05). The isometric contraction test showed a statistically significant decrease in diastolic blood pressure; a severe lesion of the segmental area of the autonomic nervous system was detected in 45% of cases.
Conclusion. A significant decrease in vagal and sympathetic activities was recorded in patients with MS.
About the Authors
A. R. Rakhmatullin
Bashkir State Medical University, Ministry of Health of Russia, Ufa, Republic of Bashkortostan, Russia 3, Lenin St., Ufa 450000, Republic of Bashkortostan
Russian Federation
Russian Federation
K. Z. Bakhtiyarova
Bashkir State Medical University, Ministry of Health of Russia, Ufa, Republic of Bashkortostan, Russia 3, Lenin St., Ufa 450000, Republic of Bashkortostan
Russian Federation
Russian Federation
R. V. Magzhanov
Bashkir State Medical University, Ministry of Health of Russia, Ufa, Republic of Bashkortostan, Russia 3, Lenin St., Ufa 450000, Republic of Bashkortostan
Russian Federation
Russian Federation
References
1. Голубева ВЛ. Вегетативные расстройства: клиника, лечение, диагностика: руководство для врачей. Москва: МИА; 2010. 640 с. [Golubeva VL. Vegetativnye rasstroistva: klinika, lechenie, diagnostika: rukovodstvo dlya vrachei [Autonomic disorders: clinical, treatment, diagnosis: a guide for physicians]. Moscow: MIA; 2010. 640 p.]
2. Данилов АБ, Окнин ВЮ, Садеков РК. Кардиоваскулярные пробы при некоторых формах патологии. Журнал невропатологии и психиатрии им. С.С. Корсакова. 1991; (5):22-5. [Danilov AB, Oknin VYu, Sadekov RK. Cardiovascular samples in some forms of pathology. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1991;(5):22-5. (In Russ.)].
3. De Seze J, Stojkovic T, Gauvrit JY, et al. Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates. J Neurol. 2001 Apr;248(4):297-303.
4. Pinter A, Cseh D, Sarkö zi A, et al. Autonomic dysregulation in multiple sclerosis. Int J Mol Sci. 2015 Jul 24;16(8):16920-52. doi:10.3390/ijms160816920.
5. Kaplan TB, Berkowitz AL, Samuels MA. Cardiovascular dysfunction in multiple sclerosis. Neurologist. 2015 Dec;20(6):108-14. doi:10.1097/NRL.0000000000000064.
6. Saari A, Tolonen U, Pä äkkö E, et al. Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clin Neurophysiol. 2004 Jun;115(6):1473-8.
7. Vita G, Fazio MC, Milone S, et al. Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions. J Neurol Sci. 1993 Dec 1;120(1):82-6.
8. Haensch CA, Jorg J. Autonomic dysfunction in multiple sclerosis. J Neurol. 2006 Feb;253 Suppl 1:I3-9.
9. Flachenecker P, Rufer A, Bihler I, et al. Fatigue in MS is related to sympathetic vasomotor dysfunction. Neurology. 2003 Sep 23;61(6):851-3.
10. Marrie RA, Reider N Cohen J. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler. 2015 Mar;21(3):318-31. doi:10.1177/1352458514564485. Epub 2014 Dec 22.
11. Михайлов ВМ. Вариабельность ритма сердца: опыт практического применения. Иваново: Ивановская государственная медицинская академия; 2002. 183 с. [Mikhailov VM. Variabel'nost' ritma serdtsa: opyt prakticheskogo primeneniya [The heart rate variability: experience of practical application]. Ivanovo: Ivanovskaya Gosudarstvennaya Meditsinskaya Akademiya; 2002. 183 p.]
12. Ewing DJ, Martin CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985 Sep-Oct;8(5):491-8.
13. Flachenecker P, Reiners K, Krauser M, et al. Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler. 2001 Oct;7(5):327-34.
14. McDougall AJ, McLeod JG. Autonomic nervous system function in multiple sclerosis. J Neurol Sci. 2003 Nov 15;215(1-2):79-85.
15. Tombul T, Anlar O, Tuncer M, et al. Impaired heart rate variability as a marker of cardiovascular autonomic dysfunction in multiple sclerosis. Acta Neurol Belg. 2011 Jun;111(2): 116-20.
16. Беленко ЕА, Воробьeва ОВ. Особенности вегетативного контроля сердечной деятельности у пациентов с ремитирующей формой рассеянного склероза. Журнал неврологии и психиатрии им. C.C. Корсакова. 2012;(112):68-71. [Belenko EA, Vorob'eva OV. Features of autonomic control of cardiac activity in patients with remitting disseminated form of multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. C.C. Korsakova. 2012;(112):68-71. (In Russ.)].
17. Chelmicka-Schorr E, Arnason BG. Nervous system-immune system interactions and their role in multiple sclerosis. Ann Neurol. 1994;36 Suppl:S29-32.
18. Котов СВ, Якушина ТИ, Лиждвой ВЮ. Ребаунд-феномен и восстановление активности рессеянного склероза при прекращении терапии финголимодом. Русский медицинский журнал. 2014;(22):1596-9. [Kotov SV, Yakushina TI, Lizhdvoi VYu. Rebound- phenomenon and the recovery of activity of multiple sclerosis during the therapy with fingolimod. Russkii meditsinskii zhurnal. 2014;(22):1596-9. (In Russ.)].
19. Котов СВ, Федорова СИ, Якушина ТИ, Лиждвой ВЮ. Опыт применения финголимода (гилениа) у пациентов с ремиттирующим течением рассеянного склероза. Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;(2):74-8. [Kotov SV, Fedorova SI, Yakushina TI, Lizhdvoi VYu. Experience in the use of fingolimod (gilenia) in patients with relapsing-remitting course of multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;(2):74-8. (In Russ.)].
20. Бойко АН. Рекомендации по использованию препарата финголимод (Гилениа) для патогенетического лечения рассеянного склероза. Медицинский совет. 2012;(4):77-82. [Boiko AN. Recommendations for the use of fingolimod (Gilenia) for pathogenetic treatment of multiple sclerosis. Meditsinskii sovet. 2012;(4):77-82. (In Russ.)].
21. Попова ЕВ, Бойко АН, Бойко ОВ. Результаты рандомизированного многоцентрового сравнительного исследования переносимости и безопасности препарата Гилениа (финголимод) у пациентов с ремитирующим рассеянным склерозом (ГИМН). Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;115(2):45-50. [Popova EV, Boiko AN, Boiko OV. The results of a randomized multicenter comparative study of the tolerability and safety of the drug Gilenia (fingolimod) in patients with remitting disseminated sclerosis (GIMN). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(2): 45-50. (In Russ.)].
Review
For citations:
Rakhmatullin A.R., Bakhtiyarova K.Z., Magzhanov R.V. Cardiointervalography in patients with multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics. 2016;8(3):39-42. (In Russ.) https://doi.org/10.14412/2074-2711-2016-3-39-42
Views: 384
Email this article 